Notes
peginterferon-α or peginterferon-β
2015 US dollars
Reference
Goyal A, et al. Cost-Effectiveness of Peg-Interferon, Interferon and Oral Nucleoside Analogues in the Treatment of Chronic Hepatitis B and D Infections in China. Clinical Drug Investigation : 11 May 2016. Available from: URL: http://doi.org/10.1007/s40261-016-0409-8
Rights and permissions
About this article
Cite this article
Peginterferon cost effective for HBV and HDV in China. PharmacoEcon Outcomes News 754, 22 (2016). https://doi.org/10.1007/s40274-016-3092-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-016-3092-3